SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPearson Regulatory News (PSON)

Share Price Information for Pearson (PSON)

Share Price is delayed by 15 minutes
Get Live Data
1,147.00    10.50 (0.92%)
Bid:
1,144.00
Ask:
1,145.00
Spread: 1.00 (0.087%)
Market Cap: £6.89b
PSON Live PriceLast checked at - London Stock Exchange

Intraday Pearson Share Chart

Contract

19 Apr 2022 07:00

RNS Number : 5041I
Pearson PLC
19 April 2022
 

19 April 2022

 

Pearson plc

("Pearson")

 

Pearson's OPM contract with ASU to end in 2023 - no change to Group guidance

LONDON, 19 APRIL 2022: Pearson, the world's leading learning company, today announces that its Online Program Management (OPM) partnership with Arizona State University (ASU) will end in June 2023 and reiterates existing Group financial guidance.

 

Over the last 10 years, the ground-breaking collaboration between Pearson and ASU has helped the university enhance and expand its online learning services and resources. Together, ASU and Pearson share a deep commitment to making an impact on the lives of learners and this highly successful partnership has helped tens of thousands of students to reach their potential by obtaining a college degree. 

 

The profit impact of the contract termination will be modest in 2022 and 2023 and will be offset thereafter through eliminating related costs and re-directing investment across our strategic growth opportunities. There is no change to the Group financial guidance for 2022 that we laid out at our preliminary results in February this year and our medium-term Group level guidance is also unchanged. We continue to expect to achieve mid-single digit Group revenue CAGR from 2022 to 2025 and for Group margins to remain relatively stable in the near term, as we invest to drive growth, improving by 2025 to mid-teens.

 

This announcement contains inside information.

 

---ENDS---

 

Contacts

 

Investor Relations

Jo Russell

James Caddy

+44 (0) 7785 451 266

+44 (0) 7825 948 218

 

Media

Tom Steiner

Gemma Terry

+44 (0) 7787 415 891

+44 (0) 7841 363 216

 

Teneo

Charles Armitstead

+44 (0) 7703 330 269

 

 

Forward looking statements

Except for the historical information contained herein, the matters discussed in this statement include forward-looking statements. In particular, all statements that express forecasts, expectations and projections with respect to future matters, including trends in results of operations, margins, growth rates, overall market trends, the impact of interest or exchange rates, the availability of financing, anticipated costs savings and synergies and the execution of Pearson's strategy, are forward-looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that will occur in future. They are based on numerous assumptions regarding Pearson's present and future business strategies and the environment in which it will operate in the future.

 

There are a number of factors which could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, including a number of factors outside Pearson's control. These include international, national and local conditions, as well as competition. They also include other risks detailed from time to time in Pearson's publicly-filed documents and you are advised to read, in particular, the risk factors set out in Pearson's latest annual report and accounts, which can be found on its website (plc.pearson.com). Any forward-looking statements speak only as of the date they are made, and Pearson gives no undertaking to update forward-looking statements to reflect any changes in its expectations with regard thereto or any changes to events, conditions or circumstances on which any such statement is based. Readers are cautioned not to place undue reliance on such forward-looking statements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTEAELPFSXAEAA
Date   Source Headline
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20264:02 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSAnnouncement of share repurchase programme
19th Jan 20267:00 amRNSHolding(s) in Company
16th Jan 202612:23 pmRNSBlock listing Interim Review
14th Jan 20267:00 amRNSPearson 2025 Trading Update: January 2026
6th Jan 20264:00 pmRNSDirector/PDMR Shareholding
2nd Jan 202610:30 amRNSTotal Voting Rights
15th Dec 20253:01 pmRNSDirector/PDMR Shareholding
12th Dec 20259:01 amRNSDirector/PDMR Shareholding
9th Dec 20258:34 amRNSHolding(s) in Company
5th Dec 202512:12 pmRNSCommittee Appointment
1st Dec 202511:00 amRNSTotal Voting Rights
1st Dec 202510:45 amRNSBlock listing Interim Review
26th Nov 20254:00 pmRNSDirector/PDMR Shareholding
26th Nov 20254:00 pmRNSHolding(s) in Company
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 202510:06 amRNSTotal Voting Rights
3rd Nov 20259:46 amRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20259:23 amRNSDirectorate Change
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20254:00 pmRNSHolding(s) in Company
17th Oct 20257:00 amRNSPearson 2025 Nine Month Trading Update
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20254:00 pmRNSAdditional Listing
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20253:45 pmRNSDirector Declaration
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.